There is more wellness news in a week than anyone reasonably needs to consume. Weekly Signal is the edit: a handful of developments worth knowing, what the headlines leave out, and what, if anything, they should change about Monday morning.
1. Menopause nutrition just became more specific.
A large Harvard-led analysis of 38,283 women compared 11 dietary patterns around the menopausal transition. Two patterns stood out for better weight outcomes: the Planetary Health Diet and a low-insulinemic dietary pattern designed around a healthier insulin response.
The useful takeaway is not another invitation to hunt for the perfect “menopause diet.” It is almost the opposite. Diets that all wear the healthy label may not behave identically during this transition. That gives us a better question than Which diet wins? We should be asking: what metabolic problem are we actually trying to solve?
Read: Harvard Gazette summary
2. Your wearable may be telling us something more interesting than your sleep score.
A Nature Communications study published August 22 linked multi-year Fitbit rest-activity patterns with trajectories of biological aging in 2,222 participants. Higher rhythm intensity was associated with 26–46% lower odds of accelerated aging, and some timing and regularity associations were stronger among women.
Important distinction: this is observational evidence, not proof that making your wearable graph prettier slows aging. Still, it makes rhythm, when we move and rest and how consistently, an increasingly interesting variable to watch.
Read: Nature Communications paper
3. Testosterone for menopausal women is entering a more serious regulatory conversation.
The FDA has scheduled a September 17 public workshop specifically on testosterone use in menopausal women. Topics include sexual function, cognition, mood, musculoskeletal health, measurement challenges, and long-term cardiovascular and breast safety.
The most useful part of the announcement may be the agency’s acknowledgement of what we still do not know. Growing popularity is not the same as settled evidence, and this is exactly the sort of area where cultural enthusiasm can outrun careful science.
Read: FDA public workshop notice
4. Perimenopause metabolism deserves something better than “eat less.”
A clinical review published August 17 examines metabolic changes during perimenopause and the nutritional considerations surrounding them. Placed beside the Harvard findings above, it points toward a more mature midlife nutrition conversation, one that cannot be reduced to discipline, calories, or whichever food has become fashionable this month.
Read: Current Nutrition Reports review
5. Longevity tech is becoming an operating system, not a gadget category.
One of the more interesting commercial signals this week is the migration from isolated devices toward platforms combining wearables, labs, imaging, and AI interpretation. That sounds wonderfully futuristic and creates a familiar problem: more measurements do not automatically produce better decisions.
For AbundantlyMari, this is one to watch rather than one to rush toward.
Read: Vogue: The Exec’s Guide to Longevity Tech
From the AbundantlyMari archive
- Your Wearable Says You Slept Fine. You Disagree. Who’s Right?
- Protein Is in Everything Now. Do You Actually Need That Much?
- The Midlife Muscle Conversation Is Bigger Than Weight Loss
One thing to carry into next week
Before adding another health intervention, ask: What decision will this information allow me to make differently?
If there is no answer yet, you may not need more data. You may simply need time to understand the data you already have.
AbundantlyMari is educational and informational only and does not provide personal medical advice.
AbundantlyMari 
Leave a comment